Ligand Pharmaceuticals (United States)

510 papers and 34.3k indexed citations i.

About

In recent decades, authors affiliated with Ligand Pharmaceuticals (United States) have published 510 papers, which have received a total of 34.3k indexed citations. Scholars at this organization have produced 293 papers in Molecular Biology, 207 papers in Genetics and 88 papers in Oncology on the topics of Estrogen and related hormone effects (193 papers), Retinoids in leukemia and cellular processes (161 papers) and Antioxidant Activity and Oxidative Stress (44 papers). Their work is cited by papers focused on Molecular Biology (20.5k citations), Genetics (10.2k citations) and Oncology (5.9k citations). Authors at Ligand Pharmaceuticals (United States) collaborate with scholars in United States, France and United Kingdom and have published in prestigious journals including Nature, Science and Cell. Some of Ligand Pharmaceuticals (United States)'s most productive authors include William W. Lamph, Richard A. Heyman, Keith B. Marschke, A. Negro‐Vilar and Marcus F. Boehm.

In The Last Decade

Fields of papers published by authors at Ligand Pharmaceuticals (United States)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Ligand Pharmaceuticals (United States) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Ligand Pharmaceuticals (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Ligand Pharmaceuticals (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Ligand Pharmaceuticals (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ligand Pharmaceuticals (United States) more than expected).

Rankless by CCL
2025